Cargando…
The Small Tellurium Compound AS101 Ameliorates Rat Crescentic Glomerulonephritis: Association with Inhibition of Macrophage Caspase-1 Activity via Very Late Antigen-4 Inactivation
Crescentic glomerulonephritis (CGN) is the most aggressive form of GN and, if untreated, patients can progress to end-stage renal failure within weeks of presentation. The α4β1 integrin very late antigen-4 (VLA-4) is an adhesion molecule of fundamental importance to the recruitment of leukocytes in...
Autores principales: | Hachmo, Yafit, Kalechman, Yona, Skornick, Itai, Gafter, Uzi, Caspi, Rachel R., Sredni, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339302/ https://www.ncbi.nlm.nih.gov/pubmed/28326083 http://dx.doi.org/10.3389/fimmu.2017.00240 |
Ejemplares similares
-
AS101 Prevents Diabetic Nephropathy Progression and Mesangial Cell Dysfunction: Regulation of the AKT Downstream Pathway
por: Shemesh, Itay Israel, et al.
Publicado: (2014) -
Tellurium Compounds Prevent and Reverse Type-1 Diabetes in NOD Mice by Modulating α4β7 Integrin Activity, IL-1β, and T Regulatory Cells
por: Yossipof, Tom Eitan, et al.
Publicado: (2019) -
The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes
por: Halperin-Sheinfeld, Meital, et al.
Publicado: (2012) -
Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017) -
Crescentic glomerulonephritis in children
por: Mayer, Ulrike, et al.
Publicado: (2020)